Recruiting studies: Early Stage Lung Cancer I And Ii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454 Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Phase 1/Phase 2 · 3 location(s) · Filamon LTD · NCT06926075 A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Diseas
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07323732 Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05327023 Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
Phase 2 · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT03351842 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · 745 location(s) · Alliance for Clinical Trials in Oncology · NCT05334069 Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
Phase N/A · 4 location(s) · Scientific Institute San Raffaele · NCT06737107

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.